192 related articles for article (PubMed ID: 32037399)
1. Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma.
Berg HF; Ju Z; Myrvold M; Fasmer KE; Halle MK; Hoivik EA; Westin SN; Trovik J; Haldorsen IS; Mills GB; Krakstad C; Werner HMJ
Br J Cancer; 2020 Mar; 122(7):1014-1022. PubMed ID: 32037399
[TBL] [Abstract][Full Text] [Related]
2. Predictability of lymph node involvement in uterus-confined endometrioid endometrial cancer by tumour size, pattern and location measured with transvaginal ultrasonography: can we save time?
Khatib G; Vardar MA; Güzel AB; Küçükgöz Güleç Ü; Köse S; Seyfettinoğlu S; Sucu M; Gümürdülü D
J Obstet Gynaecol; 2022 Oct; 42(7):3142-3148. PubMed ID: 35934993
[TBL] [Abstract][Full Text] [Related]
3. Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer.
Lee J; Kong TW; Paek J; Chang SJ; Ryu HS
Int J Gynecol Cancer; 2016 Nov; 26(9):1630-1635. PubMed ID: 27654258
[TBL] [Abstract][Full Text] [Related]
4. The preoperative serum CA125 can predict the lymph node metastasis in endometrioid-type endometrial cancer.
Ünsal M; Kimyon Comert G; Karalok A; Basaran D; Turkmen O; Boyraz G; Tasci T; Koc S; Boran N; Tulunay G; Turan T
Ginekol Pol; 2018; 89(11):599-606. PubMed ID: 30508211
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
6. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-based risk model for preoperative prediction of lymph-node metastases in women with endometrial cancer: model-development study.
Eriksson LSE; Epstein E; Testa AC; Fischerova D; Valentin L; Sladkevicius P; Franchi D; Frühauf F; Fruscio R; Haak LA; Opolskiene G; Mascilini F; Alcazar JL; Van Holsbeke C; Chiappa V; Bourne T; Lindqvist PG; Van Calster B; Timmerman D; Verbakel JY; Van den Bosch T; Wynants L
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):443-452. PubMed ID: 31840873
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group.
Stålberg K; Kjølhede P; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Falconer H; Holmberg E; Staf C; Tholander B; Åvall-Lundqvist E; Rosenberg P; Högberg T
Int J Cancer; 2017 Jun; 140(12):2693-2700. PubMed ID: 28340503
[TBL] [Abstract][Full Text] [Related]
9. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue.
Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T
Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel predictive model for lymph node metastasis in patients with endometrial endometrioid carcinoma.
Guo X; Lin C; Zhao J; Tang M
BMC Cancer; 2022 Dec; 22(1):1333. PubMed ID: 36539714
[TBL] [Abstract][Full Text] [Related]
11. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
[TBL] [Abstract][Full Text] [Related]
12. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort study.
Huang SY; Fu HC; Wu CH; Wang SC; Ou YC; Tsai CC; Chen YY; Huang SW; Wang YW; Lin H
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11807-11813. PubMed ID: 37405474
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
[No Abstract] [Full Text] [Related]
15. Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer.
Kang S; Thompson Z; McClung EC; Abdallah R; Lee JK; Gonzalez-Bosquet J; Wenham RM; Chon HS
Int J Gynecol Cancer; 2018 Feb; 28(2):260-266. PubMed ID: 29194195
[TBL] [Abstract][Full Text] [Related]
16. Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer.
Mahdi H; Munkarah AR; Ali-Fehmi R; Woessner J; Shah SN; Moslemi-Kebria M
Arch Gynecol Obstet; 2015 Jul; 292(1):183-90. PubMed ID: 25549769
[TBL] [Abstract][Full Text] [Related]
17. [Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types].
Li LL; Li H; Li J; Zhang XB; Wang ZQ; Shen DH; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):733-741. PubMed ID: 37849254
[No Abstract] [Full Text] [Related]
18. Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement.
Boren T; Lea J; Kehoe S; Miller DS; Richardson D
Gynecol Oncol; 2012 Oct; 127(1):43-6. PubMed ID: 22713294
[TBL] [Abstract][Full Text] [Related]
19. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
[TBL] [Abstract][Full Text] [Related]
20. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.
Rauh-Hain JA; Vargas RJ; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
Am J Clin Oncol; 2016 Feb; 39(1):43-8. PubMed ID: 24390270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
